Ledipasvir and sofosbuvir and Rifampin interaction

Ledipasvir and sofosbuvir and Rifampin: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ledipasvir and sofosbuvir label · effective 2025-01-10

Major

Antimycobacterials: rifabutin rifampin rifapentine ↓ ledipasvir ↓ sofosbuvir Coadministration of ledipasvir and sofosbuvir with rifampin, rifabutin, or rifapentine is not recommended [see Warnings and Precautions (5.3) ].

Drug interactionsnames RifampinView label on DailyMed
Major

Use of ledipasvir and sofosbuvir with P-gp inducers is not recommended.

Drug interactionsby drug classView label on DailyMed
Major

John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of ledipasvir and sofosbuvir, and the use with P-gp inducers is not recommended with ledipasvir and sofosbuvir [see Warnings and Precautions (5.3) ] .

Drug interactionsby drug classView label on DailyMed
Major

John's wort, a P-gp inducer, is not recommended [see Warnings and Precautions (5.3) ].

Drug interactionsby drug classView label on DailyMed
Moderate

Risk of Reduced Therapeutic Effect Due to Use with P-gp Inducers The concomitant use of ledipasvir and sofosbuvir and P-gp inducers may significantly decrease ledipasvir and sofosbuvir plasma concentrations and may lead to a reduced therapeutic effect of ledipasvir and sofosbuvir.

Warnings and precautionsby drug classView label on DailyMed

From the Rifampin label · effective 2026-05-05

Major

…Management: Avoid concomitant use Decrease exposure Hepatitis C Antiviral Prevention or Management: Avoid concomitant use Daclatasvir Decrease AUC by 79% Simeprevir Decrease AUC by 48% Sofosbuvir Decrease AUC by 72% Coadministration of sofosbuvir with rifampin may decrease sofosbuvir plasma concentrations, leading to reduced therapeutic effect of sofosbuvir.

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.